Litcius/Paper detail

Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature

Romy E. van Weelderen, Kim Klein, Meyrina D Natawidjaja, Ralph de Vries, Gertjan J.L. Kaspers

2021Expert Review of Anticancer Therapy29 citationsDOIOpen Access PDF

Abstract

: The substantially inferior treatment outcomes of pediatric AML in LMICs emphasize the unprecedented importance of global initiatives and international collaborations to improve the survival of these patients. A coordinated approach is necessary to carry out country-specific situational analyses. These analyses will result in operational plans on how to structurally implement childhood cancer registries, align healthcare infrastructure, build on capacities, and provide universal health coverage in LMICs. In addition, we strongly recommend that, in the future, LMICs document, analyze, and publish pediatric AML treatment outcomes in a more structured and uniform manner.

Topics & Concepts

MedicineMyeloid leukemiaLow and middle income countriesDeveloping countryChildhood cancerPopulationIntensive care medicinePediatricsEnvironmental healthCancerInternal medicineEconomic growthEconomicsAcute Lymphoblastic Leukemia researchChildhood Cancer Survivors' Quality of LifeAcute Myeloid Leukemia Research